Cannabis Insurance Litigation: Coverage Disputes and Legal Precedents

Executive Summary

Cannabis insurance litigation has emerged as a critical battleground where state-legal marijuana businesses confront federal prohibition's collateral consequences in the civil court system. As the cannabis industry matured from $13.2 billion in U.S. sales in 2019 to over $33 billion by 2023, operators discovered that securing and maintaining commercial insurance coverage remains fraught with legal uncertainty. Insurers frequently deny claims, rescind policies, or refuse to underwrite cannabis businesses altogether, citing federal illegality under the Controlled Substances Act (21 U.S.C. § 812) despite state licensure. Recent litigation in Illinois and across multiple jurisdictions has forced courts to reconcile conflicting state and federal law, with profound implications for risk management, capital formation, and the viability of compliant cannabis operations. These cases test whether insurers can invoke federal prohibition as grounds to void contracts governed by state law, and whether cannabis businesses can access the same legal protections as any other commercial enterprise.

Why Cannabis Insurance Litigation Matters

The inability to secure reliable insurance coverage threatens the operational stability of more than 15,000 licensed cannabis businesses across 38 states and creates systemic risks for patients, employees, and communities. Without enforceable insurance, cannabis cultivators face uninsured crop losses from fire, flood, or contamination that can exceed $5 million per facility. Dispensaries operate without liability protection if a customer suffers injury on premises. Transportation companies move millions of dollars in product without cargo coverage. Employees work in extraction labs handling volatile solvents without workers' compensation guarantees in some jurisdictions. The financial exposure extends beyond individual operators. Landlords who lease to cannabis tenants discover their property insurance may be void. Equipment lenders find their collateral uninsured. Municipalities that license dispensaries face potential liability gaps if incidents occur at permitted facilities. Insurance litigation outcomes directly affect whether institutional capital will flow into the sector. Private equity firms and real estate investment trusts require comprehensive insurance as a condition of investment. The absence of reliable coverage or the risk of retroactive policy rescission creates deal-breaking uncertainty. According to the National Cannabis Industry Association, insurance availability ranked as the third-highest operational concern in their 2024 member survey, behind only banking access and federal rescheduling uncertainty. For patients, insurance gaps create access risks. If a cultivation facility suffers an uninsured catastrophic loss, supply chains contract and prices spike. If a manufacturer's product liability coverage proves unenforceable, contaminated products may reach consumers without recourse for damages.

Background and History: From Gray Market to Courtroom

Cannabis insurance litigation evolved through three distinct phases as the industry transitioned from underground economy to regulated market between 1996 and 2026.

Phase One: The Coverage Desert (1996-2012)

When California voters approved Proposition 215 in 1996, creating the nation's first medical marijuana program, the insurance industry responded with near-total withdrawal from the sector. Major carriers including State Farm, Allstate, and Liberty Mutual issued internal guidance prohibiting coverage for any cannabis-related risk, treating marijuana businesses as categorically uninsurable regardless of state law compliance. This created what industry participants called the "coverage desert." Early dispensaries and cultivation operations self-insured or operated without coverage entirely. Some obtained policies by omitting cannabis activities from applications—a practice that would later spawn the first wave of rescission litigation. The federal government reinforced insurer reluctance through Department of Justice enforcement actions. The 2011 Cole Memo, while deprioritizing prosecution of state-compliant operators, explicitly warned that "persons who are in the business of cultivating, selling or distributing marijuana, and those who knowingly facilitate such activities, are in violation of the Controlled Substances Act, regardless of state law." Insurers interpreted this as legal jeopardy for underwriting cannabis risks.

Phase Two: Specialty Market Emergence (2012-2018)

Colorado and Washington's 2012 recreational legalization votes created the first adult-use markets, generating demand for sophisticated commercial insurance products. A handful of specialty insurers entered the space, including Cannasure Insurance Services (founded 2013), Marijuana Insurance Agency (2014), and Cannabis Insurance Group (2015). These pioneers developed cannabis-specific policies with premiums 200-400% higher than comparable non-cannabis businesses. A typical dispensary paid $15,000-25,000 annually for $1 million in general liability coverage that would cost a conventional retailer $3,000-5,000. Cultivators faced even steeper rates due to crop loss exposure. The first major insurance litigation emerged during this period when insurers began denying claims and rescinding policies after losses occurred. In 2016, a Washington state cultivation facility suffered a fire causing $2.3 million in damage. The insurer denied the claim, arguing the policy was void ab initio because cannabis cultivation violated federal law. The resulting lawsuit, settled confidentially in 2017, established the pattern for hundreds of subsequent disputes. California's 2016 passage of Proposition 64 and the subsequent 2018 implementation of comprehensive commercial regulations accelerated both market growth and litigation volume. The state's Bureau of Cannabis Control required licensees to maintain minimum insurance coverage, creating a regulatory mandate that collided with insurer reluctance.

Phase Three: Mainstream Collision (2018-Present)

As cannabis normalization accelerated, traditional insurers began cautiously entering the market through specialty divisions or wholesale partnerships. Nationwide, Travelers, and The Hartford developed limited cannabis programs. Lloyd's of London syndicates began binding policies for larger operators. This mainstream entry triggered a new litigation wave. Policyholders who believed they had secured coverage from reputable carriers discovered exclusions, limitations, and denial grounds buried in policy language. Insurers invoked federal illegality not as a blanket bar to coverage, but as a defense to specific claims. The 2024 DEA notice of proposed rulemaking to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act intensified litigation strategy on both sides. Insurers argued that ongoing Schedule I status justified coverage denials. Cannabis operators countered that the federal government's acknowledgment of medical value and lower abuse potential undermined illegality defenses. By 2026, cannabis insurance litigation had generated published opinions in at least 12 states, with divergent outcomes creating a patchwork of precedent. The Illinois case spotlighted in May 2026 represented the latest front in this evolving legal battle.

Key Players in Cannabis Insurance Litigation

Specialty Cannabis Insurers

Cannasure Insurance Services, founded in 2013, became the largest dedicated cannabis insurance broker, placing over $400 million in annual premiums by 2025. The company partners with surplus lines carriers willing to assume cannabis risk at premium rates. Cannasure has been named as a defendant in multiple lawsuits alleging inadequate disclosure of policy limitations and federal illegality defenses. Global Cannabinoids Insurance Syndicate, a Lloyd's of London consortium formed in 2019, provides high-limit coverage for multi-state operators and large cultivation facilities. The syndicate's policies explicitly acknowledge federal Schedule I status and include detailed exclusions for losses "arising from federal enforcement action."

Traditional Carriers

The Hartford launched a cannabis division in 2022, offering workers' compensation, general liability, and property coverage in select states. The company's entry signaled mainstream acceptance but came with restrictive underwriting. Hartford policies limit coverage to "ancillary" cannabis businesses—testing labs, software providers, packaging manufacturers—while excluding cultivation, processing, and retail. Nationwide developed a landlord protection product in 2023 for property owners leasing to cannabis tenants, addressing the coverage gap that left real estate investors exposed. The product has faced litigation over whether it covers losses arising from tenant activities versus property damage alone.

Plaintiff Law Firms

Vicente LLP, a Portland-based firm founded by cannabis attorney Hilary Bricken, has represented operators in insurance disputes across eight states. The firm's litigation strategy emphasizes state contract law supremacy over federal prohibition in civil disputes between private parties. Greenspoon Marder's Cannabis Law Practice Group has handled insurance coverage litigation for multi-state operators, including cases involving product liability claims and crop loss disputes. The firm argues that insurers cannot accept premiums under state-legal frameworks while invoking federal illegality to deny claims.

Defense Firms Representing Insurers

Sedgwick LLP's Insurance Coverage Group has defended major carriers in cannabis litigation, successfully arguing in multiple jurisdictions that public policy bars enforcement of contracts facilitating federally illegal activity. The firm's 2023 victory in a Michigan appellate case established precedent that insurers can rescind policies based on material misrepresentation when applicants omit cannabis activities.

Trade Associations and Advocacy Groups

The National Cannabis Industry Association has filed amicus briefs in key insurance cases, arguing that denial of coverage undermines state regulatory schemes and creates public safety hazards. NCIA's 2025 white paper documented 347 reported insurance disputes across 28 states. The American Property Casualty Insurance Association, representing traditional insurers, has advocated for federal clarity before expanding cannabis coverage. APCIA's position is that Schedule I status creates untenable legal risk for carriers regardless of state law.

Legal and Regulatory Framework

Cannabis insurance litigation operates at the intersection of federal drug prohibition, state contract law, insurance regulation, and constitutional federalism principles.

Federal Controlled Substances Act

The Controlled Substances Act, codified at 21 U.S.C. § 801 et seq., classifies marijuana as a Schedule I controlled substance, defined as having "no currently accepted medical use" and "high potential for abuse." Schedule I status makes cultivation, distribution, and possession federal felonies punishable by up to life imprisonment for large-scale operations. Insurers invoke 21 U.S.C. § 812 as grounds to void cannabis-related policies, arguing that contracts facilitating Schedule I violations are unenforceable as contrary to federal public policy. This defense rests on the common law principle that courts will not enforce agreements requiring illegal conduct. The Rohrabacher-Farr Amendment (later Rohrabacher-Blumenauer), first enacted in 2014 and renewed annually through 2026, prohibits the Department of Justice from using federal funds to interfere with state medical cannabis programs. Cannabis litigants cite this provision as evidence that federal public policy no longer categorically opposes state-legal marijuana activity, weakening insurers' illegality defense.

State Insurance Codes and Contract Law

State insurance regulations govern policy formation, claims handling, and insurer conduct. California Insurance Code § 331 prohibits "unfair claim settlement practices," including denial of claims without reasonable investigation. Cannabis operators have invoked such statutes to argue that insurers cannot accept premiums while planning to deny claims based on federal law. Contract law principles of good faith and fair dealing apply to insurance policies. Courts in Colorado, Oregon, and Nevada have held that insurers must disclose federal illegality defenses at the time of policy issuance or waive the right to invoke them later. This "duty to disclose" theory has produced plaintiff victories in cases where insurers accepted premiums for years before denying claims.

State Cannabis Licensing Requirements

Many state regulatory frameworks mandate minimum insurance coverage as a licensing condition. Illinois's Cannabis Regulation and Tax Act requires dispensaries to maintain at least $1 million in general liability coverage. Michigan's Marijuana Regulatory Agency requires cultivators to carry product liability insurance. These mandates create a legal paradox: operators must obtain insurance to comply with state law, but insurers may deny coverage based on federal illegality. Courts have split on whether regulatory mandates estop insurers from federal law defenses.

Bankruptcy Code Exclusions

The U.S. Bankruptcy Code bars cannabis businesses from bankruptcy protection because debtors cannot be engaged in ongoing illegal activity. This federal exclusion has spillover effects in insurance litigation—insurers argue that if cannabis operators cannot access bankruptcy, they similarly cannot enforce insurance contracts in federal or state courts.

State-by-State Litigation Landscape

Cannabis insurance disputes have produced divergent outcomes across state courts, creating a patchwork of precedent that affects coverage availability and pricing.

California

California courts have generally favored cannabis policyholders in insurance disputes. In a 2022 unpublished opinion, the Los Angeles Superior Court held that an insurer could not rescind a dispensary's policy based on federal illegality after accepting premiums for three years. The court found the rescission violated California Insurance Code provisions requiring good faith claims handling. California's regulatory mandate requiring licensed operators to maintain insurance has been cited by courts as evidence that state public policy favors enforcement of cannabis insurance contracts. However, California appellate courts have not yet issued published opinions creating binding precedent.

Colorado

Colorado's cannabis insurance litigation has focused on crop loss claims. In a 2021 case, a Denver district court enforced a $1.8 million crop insurance policy after a cultivation facility suffered contamination, rejecting the insurer's federal illegality defense. The court held that Colorado's constitutional amendment legalizing cannabis established state public policy favoring contract enforcement. Colorado's Division of Insurance issued guidance in 2023 clarifying that insurers doing business in the state must honor cannabis-related policies unless federal enforcement action directly causes the loss. This regulatory position has reduced litigation volume but increased premiums.

Illinois

The May 2026 Illinois case involves a dispute between a licensed cannabis transporter and its cargo insurer over a $450,000 theft claim. The insurer denied coverage, arguing that transporting Schedule I substances violates federal law and renders the policy void. The transporter counters that Illinois's Cannabis Regulation and Tax Act specifically authorizes licensed transportation and requires insurance coverage. The case is pending in Cook County Circuit Court. Industry observers view it as a potential landmark because Illinois's regulatory scheme is among the nation's most comprehensive, with detailed insurance requirements for every license type. A ruling favoring the insurer could destabilize Illinois's $1.5 billion cannabis market by making required coverage unenforceable.

Michigan

Michigan appellate courts issued a 2023 decision favoring insurers, holding that material misrepresentation on an insurance application—specifically, omitting cannabis activities—justified policy rescission regardless of state legalization. The court distinguished between enforcing cannabis contracts (which state law permits) and requiring insurers to cover risks they did not knowingly assume. This ruling has made Michigan one of the most challenging states for cannabis insurance, with carriers requiring detailed disclosures and charging premium surcharges of 300-500% over comparable non-cannabis risks.

Nevada

Nevada's insurance commissioner issued a 2024 bulletin stating that insurers cannot categorically refuse to underwrite state-licensed cannabis businesses. The bulletin requires carriers to evaluate cannabis risks using the same underwriting criteria applied to other industries, without blanket exclusions based on federal law. This regulatory intervention has expanded coverage availability in Nevada but triggered pushback from national carriers who argue the state cannot compel them to violate federal law.

Oregon

Oregon courts have applied traditional contract interpretation principles to cannabis insurance disputes, focusing on policy language rather than federal prohibition. In a 2023 case, the Oregon Court of Appeals held that an insurer could not deny a fire loss claim based on federal illegality when the policy contained no exclusion for federally illegal activities and the insurer had conducted underwriting knowing the risk involved cannabis. Oregon's approach treats cannabis insurance like any other commercial contract, with federal law relevant only if explicitly incorporated into policy terms.

Market and Business Implications

Insurance litigation uncertainty imposes quantifiable costs on cannabis operators, constrains capital formation, and distorts market competition.

Premium Inflation and Coverage Gaps

Litigation risk drives premium inflation across all cannabis insurance lines. According to a 2025 survey by MJ Biz Daily, average annual insurance costs for cannabis businesses increased 23% between 2023 and 2025, compared to 8% for non-cannabis commercial policies. A typical multi-state operator with 15 dispensaries pays $400,000-600,000 annually for comprehensive coverage that would cost a conventional retailer $80,000-120,000. Product liability coverage remains particularly expensive and limited. Cannabis edibles manufacturers pay premiums of $50,000-100,000 for $2 million in coverage, with deductibles of $100,000-250,000. Many smaller manufacturers operate without product liability insurance due to cost, creating consumer protection gaps.

Impact on Multi-State Operators

Large MSOs face complex insurance challenges as they expand across state lines. Curaleaf, Trulieve, and Green Thumb Industries each operate in 15+ states with varying insurance requirements and litigation precedents. These companies typically maintain a patchwork of policies—specialty cannabis coverage in some states, conventional commercial policies that exclude cannabis activities in others, and self-insurance for gaps. The inability to secure consistent nationwide coverage affects MSO valuations and capital raising. Institutional investors conducting due diligence require proof of comprehensive insurance. When coverage is unavailable or subject to litigation risk, investors demand higher returns or walk away entirely. This contributes to the persistent valuation discount cannabis companies face compared to other consumer packaged goods businesses.

Banking and Lending Implications

Insurance litigation intersects with cannabis banking challenges. Lenders require borrowers to maintain insurance naming the lender as loss payee. If insurance proves unenforceable, lenders face unprotected collateral risk. This compounds the existing difficulty cannabis businesses face accessing debt capital due to federal prohibition. Some lenders have responded by requiring borrowers to escrow funds equivalent to insurance coverage—effectively forcing double payment for risk protection. A cultivator might pay $150,000 in annual insurance premiums while also escrowing $500,000 to satisfy lender requirements, tying up capital that could fund expansion.

Real Estate and Property Markets

Landlords leasing to cannabis tenants face insurance uncertainty that affects property values and financing. Commercial real estate lenders typically require property owners to maintain insurance covering tenant activities. When cannabis tenants are involved, insurers may exclude tenant-related losses or charge prohibitive premiums. This has created a specialized niche of cannabis-friendly landlords who self-insure or accept higher risk in exchange for premium rents. Cannabis tenants typically pay 30-50% above market rates for comparable commercial space, partially reflecting landlord insurance costs and risks.

What Experts and Stakeholders Say

Legal scholars, insurance professionals, and industry participants offer sharply divergent views on how courts should resolve cannabis insurance disputes. According to Robert Mikos, a law professor at Vanderbilt University and cannabis federalism expert, state courts should enforce cannabis insurance contracts under state law principles without regard to federal prohibition. In his 2024 article in the Harvard Law Review, Mikos argued that federal drug law does not preempt state contract law and that the Supremacy Clause does not require state courts to apply federal public policy in private disputes. Rachel Gillette, executive director of the Colorado Cannabis Chamber of Commerce, has stated that insurance litigation uncertainty represents an existential threat to small operators. In testimony before the Colorado legislature in 2025, Gillette described a Denver dispensary that paid premiums for five years only to have a $300,000 burglary claim denied based on federal illegality, forcing the business into closure. The National Association of Insurance Commissioners has taken no official position on cannabis coverage, reflecting division among state regulators. However, individual state insurance commissioners in California, Nevada, and Illinois have issued guidance supporting contract enforcement for state-licensed operators. David Mangone, a partner at Sedgwick LLP who represents insurers in cannabis litigation, has argued that carriers cannot be compelled to underwrite federally illegal activities regardless of state law. In a 2025 interview with Insurance Journal, Mangone stated that until Congress removes cannabis from Schedule I, insurers face potential federal prosecution for facilitating drug trafficking through coverage. The American Bar Association's Section on Tort Trial and Insurance Practice published a 2024 report recommending that insurers who choose to underwrite cannabis risks should not be permitted to invoke federal illegality as a claims defense. The report argued that accepting premiums while planning to deny claims violates fundamental insurance law principles.

What's Next: Key Developments and Decision Points

Several pending cases, regulatory actions, and legislative proposals will shape cannabis insurance litigation over the next 12-24 months. The Illinois case spotlighted in May 2026 is expected to reach decision by late 2026 or early 2027. A ruling favoring the insurer could trigger a wave of policy rescissions and claim denials across Illinois's 1,800+ licensed cannabis businesses. A ruling for the operator would establish precedent that Illinois's comprehensive regulatory scheme precludes federal illegality defenses. The DEA's rescheduling process remains pending as of May 2026, with a final rule expected in late 2026 or 2027. If cannabis moves to Schedule III, insurers' federal illegality defense would weaken significantly, as Schedule III substances (including ketamine and anabolic steroids) are legally prescribed and distributed. However, Schedule III status would not eliminate federal prohibition entirely—cannabis would remain a controlled substance subject to DEA registration requirements. California's legislature is considering AB 1234, introduced in February 2026, which would explicitly prohibit insurers from denying cannabis-related claims based on federal law if the operator holds a valid state license. The bill would make California the first state to legislatively resolve the insurance litigation question. Industry observers expect similar bills in Colorado, Illinois, and Massachusetts if California's measure passes. The U.S. Court of Appeals for the Ninth Circuit is scheduled to hear oral argument in late 2026 in a case involving whether federal courts have jurisdiction over cannabis insurance disputes. The district court dismissed the case, holding that federal courts cannot adjudicate disputes involving ongoing federal crimes. The Ninth Circuit's ruling could determine whether cannabis insurance litigation remains exclusively in state courts. Several major insurers are reportedly developing "federal compliance" cannabis products that would provide coverage only for losses unrelated to federal enforcement. These policies would cover fire, theft, and general liability but exclude losses arising from DEA raids or federal prosecution. Industry reaction has been skeptical, with operators questioning whether such limited coverage justifies premium costs.

Further Reading and Primary Sources

• Controlled Substances Act, 21 U.S.C. § 801 et seq. — https://www.deadiversion.usdoj.gov/21cfr/21usc/
• California Cannabis Regulation and Tax Act, Business and Professions Code § 26000 et seq. — https://leginfo.legislature.ca.gov/
• Illinois Cannabis Regulation and Tax Act, 410 ILCS 705 — https://www.ilga.gov/legislation/ilcs/ilcs3.asp?ActID=4963
• National Cannabis Industry Association, "State of the Industry 2025" — https://thecannabisindustry.org/
• American Property Casualty Insurance Association, "Cannabis Insurance: Legal and Regulatory Challenges" (2024) — https://www.apci.org/
• Mikos, Robert A., "Preemption Under the Controlled Substances Act," 16 Journal of Health Care Law & Policy 5 (2013) — https://digitalcommons.law.umaryland.edu/jhclp/
• DEA Notice of Proposed Rulemaking, Rescheduling of Marijuana, Docket No. DEA-407 (2024) — https://www.federalregister.gov/
• Nevada Division of Insurance, Bulletin 24-003, "Underwriting Cannabis Risks" (2024) — https://doi.nv.gov/
• Colorado Division of Insurance, Guidance Document, "Insurance Coverage for Marijuana-Related Businesses" (2023) — https://doi.colorado.gov/
• National Association of Insurance Commissioners, Cannabis Insurance Working Group materials — https://content.naic.org/